GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zivo Bioscience Inc (OTCPK:ZIVO) » Definitions » E10

Zivo Bioscience (Zivo Bioscience) E10 : $-23.91 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zivo Bioscience E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zivo Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.470. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-23.91 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 10.80% per year. During the past 5 years, the average E10 Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Zivo Bioscience was 26.30% per year. The lowest was -4.70% per year. And the median was 10.40% per year.

As of today (2024-05-21), Zivo Bioscience's current stock price is $7.99. Zivo Bioscience's E10 for the quarter that ended in Mar. 2024 was $-23.91. Zivo Bioscience's Shiller PE Ratio of today is .


Zivo Bioscience E10 Historical Data

The historical data trend for Zivo Bioscience's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zivo Bioscience E10 Chart

Zivo Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.85 -30.28 -25.67 -25.37 -21.52

Zivo Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.29 -23.12 -20.85 -21.52 -23.91

Competitive Comparison of Zivo Bioscience's E10

For the Biotechnology subindustry, Zivo Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zivo Bioscience's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zivo Bioscience's Shiller PE Ratio falls into.



Zivo Bioscience E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zivo Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.47/131.7762*131.7762
=-0.470

Current CPI (Mar. 2024) = 131.7762.

Zivo Bioscience Quarterly Data

per share eps CPI Adj_EPS
201406 -4.800 100.560 -6.290
201409 -14.400 100.428 -18.895
201412 2.707 99.070 3.601
201503 -4.800 99.621 -6.349
201506 -9.600 100.684 -12.565
201509 -5.383 100.392 -7.066
201512 0.000 99.792 0.000
201603 -4.800 100.470 -6.296
201606 -9.600 101.688 -12.441
201609 -4.800 101.861 -6.210
201612 -4.800 101.863 -6.210
201703 -4.800 102.862 -6.149
201706 -4.800 103.349 -6.120
201709 -9.600 104.136 -12.148
201712 -14.400 104.011 -18.244
201803 -14.400 105.290 -18.022
201806 -9.600 106.317 -11.899
201809 -14.400 106.507 -17.817
201812 -4.800 105.998 -5.967
201903 -7.881 107.251 -9.683
201906 -3.569 108.070 -4.352
201909 -2.390 108.329 -2.907
201912 -4.999 108.420 -6.076
202003 -4.800 108.902 -5.808
202006 -1.377 108.767 -1.668
202009 -4.132 109.815 -4.958
202012 -2.200 109.897 -2.638
202103 -2.529 111.754 -2.982
202106 -1.680 114.631 -1.931
202109 -1.440 115.734 -1.640
202112 -2.080 117.630 -2.330
202203 -1.320 121.301 -1.434
202206 -1.320 125.017 -1.391
202209 -1.280 125.227 -1.347
202212 -1.680 125.222 -1.768
202303 -1.260 127.348 -1.304
202306 -1.320 128.729 -1.351
202309 -1.050 129.860 -1.065
202312 -0.960 129.419 -0.977
202403 -0.470 131.776 -0.470

Add all the adjusted EPS together and divide 10 will get our e10.


Zivo Bioscience  (OTCPK:ZIVO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zivo Bioscience E10 Related Terms

Thank you for viewing the detailed overview of Zivo Bioscience's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Zivo Bioscience (Zivo Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
21 East Long Lake Road, Suite 100, Bloomfield Hills, MI, USA, 48304
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's pipeline candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Human Food Ingredients, and Skin Health.
Executives
Alison A Cornell director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Christopher D. Maggiore officer: CHIEF FINANCIAL OFFICER 4788 NOBLES POND DR. NW, CANTON OH 44718
Nola E Masterson director 768 WEST CALIFORNIA WAY, WOODSIDE CA 94062
John Bernard Payne director 9900 NE 114TH CIRCLE, VANCOUVER WA 98662
Strome Mezzanine Fund, Lp 10 percent owner 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401
Keith Marchiando officer: Chief Financial Officer C/O ZIVO BIOSCIENCE, INC., 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS MI 48304
Mark E Strome 10 percent owner 100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401
Strome Alpha Fund L P 10 percent owner 100 WILSHIRE BLVD SUITE 1750, SANTA MONICA CA 90401
Strome Investment Management Lp 10 percent owner 100 WILSHIRE BLVD, 15TH FLOOR, SANTA MONICA CA 90401
Strome Group, Inc. 10 percent owner 100 WILSHIRE BLVD., SUITE 1750, SANTA MONICA CA 90401
Hep Investments Llc 10 percent owner 2804 ORCHARD LAKE RD, STE 205, KEEGO HARBOR MI 48320
Rondeau Robert O Jr director 70 WEST LONG LAKE RD, STE 119, TROY MI 48098
Thomas Kevin Cox director 470 MICHGAMME LANE, LAKE FOREST IL 60045
Andrew A Dahl officer: President, CEO 7 WEST SQUARE LAKE ROAD, STE 6165, BLOOMFIELD HILLS MI 48302
Brian W Young other: See remarks below. 1800 NW CORPORATE BLVD, BOCA RATON FL 33431